| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 580.74 Million | USD 997.82 Million | 7.00% | 2022 |
The global Neohesperidine DC Market size was worth around USD 580.74 Million in 2022 and is predicted to grow to around USD 997.82 Million by 2030 with a compound annual growth rate (CAGR) of roughly 7.00% between 2023 and 2030.
Neohesperidine dihydrochalcone or NHDC is derived from neo hesperidin and is used as an artificial sweetener. It was developed in the year 1960 by the United States Department of Agriculture research institute. Neohesperidine DC is sweeter than sugar. Hence, it is widely used as the flavor enhancer in the food industry. It has a color that is white to pale yellow and has no odor. Owing to its thermostability it is used in several industrial applications such as in beverages and dairy products.
Artificial non-caloric sweeteners called intense sweeteners are used to sweeten food without adding any calories. Aspartame, sucralose, acesulfame-K, neotame, neo hesperidin DC, cyclamates, and saccharin are just a few examples of the various types of sweetening agents.
Neohesperidine dihydrochalcone, also known as NHDC, is a synthetic sweetener made from Neohesperidin, a substance found in bitter reddish and citrus fruit and vegetables. It was created by American the Department of Agriculture research study sometime around 1960. By weight, NHDC has a sweeter taste than sugar by about 340 times. It is primarily used as a flavor enhancer and is an odorless, white to pale yellow substance known as a flavonoid.
In the year 1988, the European Food Safety Authority confirmed the safety of NHDC. NHDC was approved to be used as a sweetener in the food products by the European Parliament and Council Directive 94/35/EC. The use of lower concentrations of the NHDC as a flavor modifier has gained recognition.
The main end-user industry that is driving the neohesperidine DC market is the food and beverage industry. The developments that are made in the pharmaceutical and food sectors are increasing the demand for the ready-to-eat food products, packaged foodstuffs, and better alternatives for sugar are the influential factors that are triggering the growth of the market. The neohesperidine DC provides the benefit of increasing the quality of the sweetener blends, thermo-stability, flavor enhancement, and also provides health benefits for illnesses such as diabetes thus driving the growth of the market. There are several factors that limit the growth of the market which includes the increasing preference of the consumers towards natural products, the strong aftertaste of the neohesperidine DC, and the availability of better alternatives as sweetening agents. Another factor that is affecting the growth of the market is the consumption of neohesperidine DC has certain side effects such as migraine and nausea.
| Report Attributes | Report Details |
|---|---|
| Report Name | Neohesperidine DC Market Size Report |
| Market Size in 2022 | USD 580.74 Million |
| Market Forecast in 2030 | USD 997.82 Million |
| Growth Rate | CAGR of 7.00% |
| Number of Pages | 188 |
| Forecast Units | Value (USD Billion), and Volume (Units) |
| Key Companies Covered | Changsha Sunnycare Inc., Gelfix S. A., Kang Biotech, and Bordas Distillations Chinchurreta SA. |
| Segments Covered | By End-user industry, By Application and By region. |
| Base Year | 2022 |
| Historical Year | 2017 - 2021 |
| Forecast Year | 2023 - 2030 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global market for neohesperidine DC is fragmented into the end-user industry and applications.
On the basis of the end-user, the global market is segregated into animal feed, cosmetics, food and beverage, and pharmaceuticals.
The food and beverage segment is sub-segmented into carbonated and non-carbonated refreshing drinks, puddings, desserts, sweets, toothpaste, mouthwash, table-top sweeteners, dairy products, ice cream and frozen desserts, and chewing gum.
On the basis of the application, the market is categorized into sweetener and flavoring agent.
The popularity of the neohesperidine DC is growing in the Europe and the North American sweetener market. There is a significant market growth in Asia Pacific region due to the growing demand for the packaged food and the increasing inclination of the customers towards alcoholic and non-alcoholic beverages. The other factors that are contributing to the growth of the market in Asia Pacific region are rise in the living standards, growing consumption of the processed food, and the rapid rate of urbanization. In the coming years, the market for the neohesperidine DC will develop in all the regions.
The key market players that are involved in the neohesperidine DC market include -
By End-user:
By Application:
By Region
FrequentlyAsked Questions
Neohesperidine DC is an artificial sweetener and flavor enhancer. It is used in food and beverages
The global Neohesperidine DC market is expected to be driven by the demand for natural sweeteners and flavor enhancers. Use in food, beverages, and pharmaceuticals supports adoption.
According to study, the global Neohesperidine DC market size was worth around USD 580.74 Million in 2022 and is predicted to grow to around USD 997.82 Million by 2030.
The global Neohesperidine DC market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.00% during the forecast period from 2023-2030.
The global Neohesperidine DC industry is projected to be challenged by Challenges include limited consumer awareness and regulatory approvals.
The Opportunities include natural sweetener demand, flavor enhancement, low-calorie foods, and nutraceutical applications will offer significant growth opportunities in the Neohesperidine DC market.
Natural sweetener and flavor enhancer; bitterness masking; clean-label food and beverage adoption are the emerging trends and innovations impacting the Neohesperidine DC market.
The global Neohesperidine DC market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Neohesperidine DC market are; Changsha Sunnycare Inc., Gelfix S. A., Kang Biotech, and Bordas Distillations Chinchurreta SA. and others.
The report explores crucial aspects of the Neohesperidine DC market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients